ID

26167

Description

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 End of Re-Enrollment Titration Period

Keywords

Versions (1)
  1. 10/10/17 10/10/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 10, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC-ND 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

English

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

1 forms  
Patient Information
Description

Patient Information

Alias
UMLS CUI-1
C1955348
Patient No.
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1830427
Date of Visit
Description

Date of Visit

Data type

date

Measurement units
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1320303
dd-mmm-yyyy
End of Re-Enrollment Titration Period
Description

End of Re-Enrollment Titration Period

Alias
UMLS CUI-1
C1516879
UMLS CUI-2
C1272693
UMLS CUI-3
C2983683
Dose of Study Medication prescribed for Maintenance period:
Description

Dosage of study drug

Data type

float

Measurement units
  • mg/d
Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
mg/d
At which week did Titration end?
Description

End Date of Titration

Data type

float

Measurement units
  • week
Alias
UMLS CUI [1,1]
C2983683
UMLS CUI [1,2]
C0806020
week
Investigator Signature
Description

Investigator Signature

Alias
UMLS CUI-1
C2346576
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
Description

Signature

Data type

text

Alias
UMLS CUI [1]
C1519316
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
Description

Investigator's Name

Data type

text

Alias
UMLS CUI [1]
C2826892
Date
Description

Date of Report

Data type

date

Measurement units
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yyyy
Back to the top of the page

Similar models

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient No.
text
C1830427 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
End of Re-Enrollment Titration Period
C1516879 (UMLS CUI-1)
C1272693 (UMLS CUI-2)
C2983683 (UMLS CUI-3)
Dosage of study drug
Item
Dose of Study Medication prescribed for Maintenance period:
float
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
End Date of Titration
Item
At which week did Titration end?
float
C2983683 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Signature
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
text
C1519316 (UMLS CUI [1])
Investigator's Name
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
text
C2826892 (UMLS CUI [1])
Date of Report
Item
Date
date
C1302584 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial